Armouring GPC3 CAR T cells for hepatocellular carcinoma: how much is enough and what comes next?September 18, 2026
Share Facebook Twitter LinkedIn Pinterest WhatsApp Email RESEARCH HIGHLIGHT 27 March 2026 A programme that offers scans to smokers between the ages of 55 and 74 detects a large number of early-stage lung tumours. boosts campaign diagnosis Early Huge lungcancer screening
Armouring GPC3 CAR T cells for hepatocellular carcinoma: how much is enough and what comes next?September 18, 2026
TWF1 inhibition overcomes cisplatin resistance in NSCLC by inducing ferroptosis via p53-dependent SLC7A11 repression and autophagy-mediated glutathione metabolism reprogrammingSeptember 18, 2026
PGC1α-mediated upregulation of PHD2 represses HIF-signaling, limiting prostate cancer progressionSeptember 17, 2026